Nicotinamide adenine dinucleotide (NAD) is an essential coenzyme that functions as an electron carrier in the mitochondrial citric acid cycle and in the electron transport chain and is the cofactor for NAD
+-consuming enzymes, such as sirtuins (SIRTs) and poly (ADP-ribose) polymerases (PARPs). At the physiological level, SIRTs play a primary regulatory role in metastasis,
11 mitochondrial metabolism, inflammation, meiosis, autophagy, circadian rhythms, and apoptosis.
12 PARPs, including the poly-ADP-ribose polymerases and mono-ADP-ribose transferases, control numerous cellular functions, from DNA repair to gene expression.
13 NAD
+ can be synthesized through the de novo pathway from tryptophan (TRP) precursors and through two salvage pathways from nicotinic acid (NA) and nicotinamide (NAM).
14 In the majority of mammalian cells, the salvage pathway from nicotinamide represents the major source in the total NAD
+ synthesis.
15 As the rate-limiting enzyme of this pathway, nicotinamide phosphoribosyltransferase (NAMPT) converts NAM into nicotinamide mononucleotide (NMN) and further into NAD
+ by nicotinamide mononucleotide adenylyltransferase (NMNAT).
14 Given these multiple functions, NAD
+ has been reported to be important in many biological processes and diseases, including metabolism, aging, cardiomyopathy, Alzheimer's disease, and cancer.
14,16 In the degeneration-related diseases of the retina, brain, liver, skeletal muscle, and cardiomyocytes, NAD
+ content is lower, while either NAMPT overexpression or replenishment with either NAD
+ or its precursors reversed declines in cell survival.
14,17–19